Transcriptional reprogramming by mutated IRF4 in lymphoma.
Saved in:
| Title: | Transcriptional reprogramming by mutated IRF4 in lymphoma. |
|---|---|
| Authors: | Schleussner N; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Cauchy P; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; University Medical Center Freiburg, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Franke V; Bioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max-Delbrück-Center, Berlin, Germany., Giefing M; Institute of Human Genetics, Polish Academy of Sciences, Poznan, 60-479, Poland.; Institute of Human Genetics, Christian-Albrechts-University Kiel, 24105, Kiel, Germany., Fornes O; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada., Vankadari N; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC, 3000, Australia., Assi SA; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Costanza M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Weniger MA; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, 45122, Essen, Germany., Akalin A; Bioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max-Delbrück-Center, Berlin, Germany., Anagnostopoulos I; Institute of Pathology, Universität Würzburg and Comprehensive Cancer Centre Mainfranken (CCCMF), Würzburg, Germany., Bukur T; TRON gGmbH - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany., Casarotto MG; Research School of Biology, The Australian National University, Canberra, ACT, Australia., Damm F; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany., Daumke O; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Structural Biology, 13125, Berlin, Germany., Edginton-White B; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Gebhardt JCM; Department of Physics, Institute of Biophysics, Ulm University, Ulm, Germany., Grau M; Department of Physics, University of Marburg, 35052, Marburg, Germany.; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Grunwald S; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Structural Biology, 13125, Berlin, Germany., Hansmann ML; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.; Institute for Pharmacology and Toxicology, Goethe University, Frankfurt am Main, Germany., Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany., Huber L; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany., Kärgel E; Signal Transduction in Tumor Cells, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Lusatis S; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Noerenberg D; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany., Obier N; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Pannicke U; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany., Fischer A; Institute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany., Reisser A; Department of Physics, Institute of Biophysics, Ulm University, Ulm, Germany., Rosenwald A; Institute of Pathology, Universität Würzburg and Comprehensive Cancer Centre Mainfranken (CCCMF), Würzburg, Germany., Schwarz K; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany.; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Württemberg-Hessen, Ulm, Germany., Sundararaj S; Research School of Biology, The Australian National University, Canberra, ACT, Australia., Weilemann A; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Winkler W; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Xu W; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Lenz G; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Rajewsky K; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Immune Regulation and Cancer, 13125, Berlin, Germany., Wasserman WW; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada., Cockerill PN; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Scheidereit C; Signal Transduction in Tumor Cells, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Siebert R; Institute of Human Genetics, Christian-Albrechts-University Kiel, 24105, Kiel, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany., Küppers R; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, 45122, Essen, Germany., Grosschedl R; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany., Janz M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Bonifer C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Mathas S; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany. stephan.mathas@charite.de.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany. stephan.mathas@charite.de.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany. stephan.mathas@charite.de.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. stephan.mathas@charite.de. |
| Source: | Nature communications [Nat Commun] 2023 Nov 07; Vol. 14 (1), pp. 6947. Date of Electronic Publication: 2023 Nov 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37935654 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Transcriptional reprogramming by mutated IRF4 in lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schleussner+N%22">Schleussner N</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cauchy+P%22">Cauchy P</searchLink>; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; University Medical Center Freiburg, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Franke+V%22">Franke V</searchLink>; Bioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max-Delbrück-Center, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Giefing+M%22">Giefing M</searchLink>; Institute of Human Genetics, Polish Academy of Sciences, Poznan, 60-479, Poland.; Institute of Human Genetics, Christian-Albrechts-University Kiel, 24105, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Fornes+O%22">Fornes O</searchLink>; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada.<br /><searchLink fieldCode="AU" term="%22Vankadari+N%22">Vankadari N</searchLink>; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC, 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Assi+SA%22">Assi SA</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.<br /><searchLink fieldCode="AU" term="%22Costanza+M%22">Costanza M</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Weniger+MA%22">Weniger MA</searchLink>; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, 45122, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Akalin+A%22">Akalin A</searchLink>; Bioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max-Delbrück-Center, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Anagnostopoulos+I%22">Anagnostopoulos I</searchLink>; Institute of Pathology, Universität Würzburg and Comprehensive Cancer Centre Mainfranken (CCCMF), Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bukur+T%22">Bukur T</searchLink>; TRON gGmbH - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Casarotto+MG%22">Casarotto MG</searchLink>; Research School of Biology, The Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Damm+F%22">Damm F</searchLink>; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Daumke+O%22">Daumke O</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Structural Biology, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Edginton-White+B%22">Edginton-White B</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.<br /><searchLink fieldCode="AU" term="%22Gebhardt+JCM%22">Gebhardt JCM</searchLink>; Department of Physics, Institute of Biophysics, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Grau+M%22">Grau M</searchLink>; Department of Physics, University of Marburg, 35052, Marburg, Germany.; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Grunwald+S%22">Grunwald S</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Structural Biology, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hansmann+ML%22">Hansmann ML</searchLink>; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.; Institute for Pharmacology and Toxicology, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+S%22">Hartmann S</searchLink>; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Huber+L%22">Huber L</searchLink>; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kärgel+E%22">Kärgel E</searchLink>; Signal Transduction in Tumor Cells, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lusatis+S%22">Lusatis S</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Noerenberg+D%22">Noerenberg D</searchLink>; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Obier+N%22">Obier N</searchLink>; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.<br /><searchLink fieldCode="AU" term="%22Pannicke+U%22">Pannicke U</searchLink>; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Fischer+A%22">Fischer A</searchLink>; Institute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Reisser+A%22">Reisser A</searchLink>; Department of Physics, Institute of Biophysics, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Rosenwald+A%22">Rosenwald A</searchLink>; Institute of Pathology, Universität Würzburg and Comprehensive Cancer Centre Mainfranken (CCCMF), Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schwarz+K%22">Schwarz K</searchLink>; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany.; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Württemberg-Hessen, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Sundararaj+S%22">Sundararaj S</searchLink>; Research School of Biology, The Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Weilemann+A%22">Weilemann A</searchLink>; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Winkler+W%22">Winkler W</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Xu+W%22">Xu W</searchLink>; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Lenz+G%22">Lenz G</searchLink>; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Rajewsky+K%22">Rajewsky K</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Immune Regulation and Cancer, 13125, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wasserman+WW%22">Wasserman WW</searchLink>; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada.<br /><searchLink fieldCode="AU" term="%22Cockerill+PN%22">Cockerill PN</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.<br /><searchLink fieldCode="AU" term="%22Scheidereit+C%22">Scheidereit C</searchLink>; Signal Transduction in Tumor Cells, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Siebert+R%22">Siebert R</searchLink>; Institute of Human Genetics, Christian-Albrechts-University Kiel, 24105, Kiel, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Küppers+R%22">Küppers R</searchLink>; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, 45122, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Grosschedl+R%22">Grosschedl R</searchLink>; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Janz+M%22">Janz M</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bonifer+C%22">Bonifer C</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.<br /><searchLink fieldCode="AU" term="%22Mathas+S%22">Mathas S</searchLink>; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany. stephan.mathas@charite.de.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany. stephan.mathas@charite.de.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany. stephan.mathas@charite.de.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. stephan.mathas@charite.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Nov 07; Vol. 14 (1), pp. 6947. <i>Date of Electronic Publication: </i>2023 Nov 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37935654 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-023-41954-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6947 Titles: – TitleFull: Transcriptional reprogramming by mutated IRF4 in lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schleussner N – PersonEntity: Name: NameFull: Cauchy P – PersonEntity: Name: NameFull: Franke V – PersonEntity: Name: NameFull: Giefing M – PersonEntity: Name: NameFull: Fornes O – PersonEntity: Name: NameFull: Vankadari N – PersonEntity: Name: NameFull: Assi SA – PersonEntity: Name: NameFull: Costanza M – PersonEntity: Name: NameFull: Weniger MA – PersonEntity: Name: NameFull: Akalin A – PersonEntity: Name: NameFull: Anagnostopoulos I – PersonEntity: Name: NameFull: Bukur T – PersonEntity: Name: NameFull: Casarotto MG – PersonEntity: Name: NameFull: Damm F – PersonEntity: Name: NameFull: Daumke O – PersonEntity: Name: NameFull: Edginton-White B – PersonEntity: Name: NameFull: Gebhardt JCM – PersonEntity: Name: NameFull: Grau M – PersonEntity: Name: NameFull: Grunwald S – PersonEntity: Name: NameFull: Hansmann ML – PersonEntity: Name: NameFull: Hartmann S – PersonEntity: Name: NameFull: Huber L – PersonEntity: Name: NameFull: Kärgel E – PersonEntity: Name: NameFull: Lusatis S – PersonEntity: Name: NameFull: Noerenberg D – PersonEntity: Name: NameFull: Obier N – PersonEntity: Name: NameFull: Pannicke U – PersonEntity: Name: NameFull: Fischer A – PersonEntity: Name: NameFull: Reisser A – PersonEntity: Name: NameFull: Rosenwald A – PersonEntity: Name: NameFull: Schwarz K – PersonEntity: Name: NameFull: Sundararaj S – PersonEntity: Name: NameFull: Weilemann A – PersonEntity: Name: NameFull: Winkler W – PersonEntity: Name: NameFull: Xu W – PersonEntity: Name: NameFull: Lenz G – PersonEntity: Name: NameFull: Rajewsky K – PersonEntity: Name: NameFull: Wasserman WW – PersonEntity: Name: NameFull: Cockerill PN – PersonEntity: Name: NameFull: Scheidereit C – PersonEntity: Name: NameFull: Siebert R – PersonEntity: Name: NameFull: Küppers R – PersonEntity: Name: NameFull: Grosschedl R – PersonEntity: Name: NameFull: Janz M – PersonEntity: Name: NameFull: Bonifer C – PersonEntity: Name: NameFull: Mathas S IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 11 Text: 2023 Nov 07 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |